Industrial Impact, Medical

Producing therapeutic peptides using biotechnology

October 20, 2022

Producing therapeutic
We began the project by working to the design of a recombinant bacterial strain selection of a strain capable
of producing high concentrations of peptides.

Spotlight

GTP Technology

GTP Technology is a French Contract Research Organization providing custom recombinant protein production services. Founded in 2000, we have conducted to date over 1200 projects for innovative and challenging protein applications for companies from biopharmaceutical, diagnostic, agrichemistry and cosmetic industries.

OTHER WHITEPAPERS
news image

The A to Z of microarrays evolution of a revolutionary solution

whitePaper | May 27, 2023

The Human Genome Project was a monumental effort over more than a decade to determine the human DNA sequence and analyze genetic variation among individuals. The hope was that, armed with this understanding, phenotypic differences would be explainable by genetic variation, and health benefits could follow.

Read More
news image

State of the Global Biotech Landscape

whitePaper | November 22, 2022

Over the last five years, the global biotech and pharmaceutical landscape has witnessed continued growth. The analysis period encompasses a unique timeframe including the global COVID-19 pandemic.

Read More
news image

Innovative strategies to maintain product integrity in Biologic andBiosimilar clinical studies

whitePaper | August 7, 2022

The number of biologic new molecular entities approved by the FDA has increased over the last five years indicates a growing focus on biosimilar.

Read More
news image

BIOTECHNOLOGY UPDATE

whitePaper | April 24, 2022

The Global Forum on Biotechnology, established in 2010, is one of 15 Global Fora created by OECD Committees. Global Fora are not official OECD bodiesbut are best described as broad.

Read More
news image

Cell and Gene Therapy Clinical Trials

whitePaper | November 8, 2022

Using experienced-based best practices and documented tools, ICON has conducted over 63 CGT trials across multiple therapeutic areas from haematology-oncology torare and orphan diseases.

Read More
news image

Using Clinical Breakpoints to Improve Antimicrobial Resistance Detection

whitePaper | December 13, 2022

Define the ongoing pandemic of antimicrobial resistance. Discuss how we can address the ongoing pandemicin the Clinical Microbiology Laboratory

Read More

Spotlight

GTP Technology

GTP Technology is a French Contract Research Organization providing custom recombinant protein production services. Founded in 2000, we have conducted to date over 1200 projects for innovative and challenging protein applications for companies from biopharmaceutical, diagnostic, agrichemistry and cosmetic industries.

Events